Article

All in the family: disclosure of "unwanted" information to an adolescent to benefit a relative.

Department of Bioethics, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
American Journal of Medical Genetics Part A (Impact Factor: 2.05). 11/2008; 146A(21):2719-24. DOI: 10.1002/ajmg.a.32362
Source: PubMed

ABSTRACT Ethical assessments of clinical decisions are typically based on the preferences and interests of the individual patient. However, some clinical interventions, such as genetic testing or organ donation, may involve multiple family members. In these cases, one family member may have the potential to benefit, while another family member is exposed to potential physical or psychological risk. In the research setting, the balancing of benefits and risks between family members may be further complicated by uncertainty about their magnitude and likelihood. In addition, when the individual facing these apparently uncompensated risks is a child, the situation becomes particularly ethically complicated, as we appreciated in a recent case. Investigators at the National Cancer Institute were faced with a decision about whether it would be appropriate to disclose apparently "unwanted" research test results (length of telomeres in leukocyte subsets) to an adolescent about risk of future disease (dyskeratosis congenita), possibly causing psychological harm and an ethical wrong. These issues were not expected at the outset of the family's study participation but rather emerged with new data about the research tests. Disclosure of the research finding was an important consideration in order to avoid using the adolescent as a stem-cell donor for his sister. Disclosure to the adolescent could not be justified by merely considering the immediate interests and preferences of the adolescent. However, an expanded ethical analysis that considers the adolescent's familial context offers a more complete picture of the adolescent's interests and preferences which provides justification for disclosure.

Full-text

Available from: June A. Peters, Jun 15, 2015
0 Followers
 · 
113 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In this paper, we consider the nonlinear boundary value problem (BVP) for the electrohydrodynamic flow of a fluid in an ion drag configuration in a circular cylindrical conduit. We present analytical solutions based on the homotopy analysis method (HAM) for various values of the relevant parameters and discuss the convergence of these solutions. We also compare our results with numerical solutions. The results provide another example of a highly nonlinear problem in which HAM is the only known analytical method that yields convergent solutions for all values of the relevant parameters.
    Communications in Nonlinear Science and Numerical Simulation 07/2011; 16(7):2730-2736. DOI:10.1016/j.cnsns.2010.10.004 · 2.57 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite extensive debate, there is no consensus on whether individual genetic data should be disclosed to research participants. The emergence of whole-genome sequencing methods is increasingly generating unequalled amounts of genetic data, making the need for a clear feedback policy even more urgent. In this debate two positions can be broadly discerned: a restrictive disclosure policy (‘no feedback except life-saving data’) and an intermediate policy of qualified disclosure (‘feedback if the results meet certain conditions’). We explain both positions and present the principal underlying arguments. We suggest that the debate should no longer address whether genetic research results should be returned, but instead how best to make an appropriate selection and how to strike a balance between the possible benefits of disclosure and the harms of unduly hindering biomedical research.
    Trends in Genetics 02/2011; DOI:10.1016/j.tig.2010.11.004 · 11.60 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Dyskeratosis congenita (DC) is a cancer-prone inherited bone marrow failure syndrome caused by aberrant telomere biology. The mucocutaneous triad of nail dysplasia, abnormal skin pigmentation and oral leukoplakia is diagnostic, but is not always present; DC can also be diagnosed by the presence of very short leukocyte telomeres. Patients with DC are at high risk of bone marrow failure, pulmonary fibrosis, liver disease, cancer and other medical problems. Germline mutations in one of nine genes associated with telomere maintenance are present in approximately 60% of patients. DC is one among the group of clinically and biologically related telomere biology disorders, including Hoyeraal-Hreidarsson syndrome, Revesz syndrome, Coats plus (also known as cranioretinal microangiopathy with calcifications and cysts) and subsets of aplastic anemia, pulmonary fibrosis, nonalcoholic and noninfectious liver disease and leukemia. The authors review the pathobiology that connects DC and the related telomere biology disorders, methods of diagnosis and management modalities.
    Expert Review of Hematology 06/2013; 6(3):327-37. DOI:10.1586/ehm.13.23 · 2.14 Impact Factor